Stem cell technology company CellResearch Corporation has been a strategic partner of Cordlife Group since 2010.

GlaxoSmithKline, Merck & Co, Lundbeck and Partners Healthcare returned for a round that took Spero Therapeutics' overall funding to $63m.

The China-based immuno-oncology company, backed by Merck & Co since 2011, floated at the top of it range and has gained since its debut yesterday.

A potential brain aneurysm treatment device created by Oxford University spinout Oxford Endovascular has gained funding to complete manufacturing and move on to clinical trials.

The Philips-Teva joint venture has supplied four companies with upwards of $1m in funding as part of its incubator program.